In 2011 this blog was listed as one of the top 10 blog in pharma technical information it is popular amongst the pharmacists and pharma industry professionals. We have published very important and very useful information for pharma industry professionals.

Monday, March 29, 2010

US FDA ask's pharmaceutical manufacturers to stop marketing Unapproved Nitroglycerin tablets

US FDA has officially asked pharmaceutical manufacturers to stop selling nitroglycerin tablets which are not approved by US FDA.
US FDA has asked these pharmaceutical manufacturers to stop the production of nitroglycerin tablets which are not approved by US FDA, with in 90 days , and they can ship the available stock with in six months .

US FDA says safety of these unapproved products is not known , though the formulations were in sale for long time , FDA says it is required to be assured that the products are safe , the excipients, impurities , labeling of product , and clinical study data is required to be evaluated by US FDA in order to declare that the product is safe for use. Safety of a drug is automatically conferred once the US FDA approves the product for sale .
These pharmaceutical companies were able to sale their products to because of the rule for drugs whos use predates the date of establishment FDA 1938 .
Nitroglycerin tablets are sublingual dosage form , as these tablets are placed under tongue , and the drug is absorbed rapidly in to vein under tongue and drug is made available to heart ,the absorption if fast ,and is most effective in case of angina pectoris and other congestive heart disease attacks, where the drug is a potent vasodilator , helps in reliving the congestion and facilitate blood circulation , and oxygen supply is increased, it improves availability of oxygen to heart muscles , it is a critical and life saving drug. Nitroglycerin tablets are marketed in 0.3 mg, 0.4 mg, and 0.6 mg dosages.

As of no the only US FDA approved nitroglycerin tablets are those of Pfizer Inc , FDA said that ,they do not anticipate any supply problems.

Nitroglycerin (1,2,3-glyceryl trinitrate )


Nitroglycerin is a molecule which is a nitrated compound of glycerin ,Glycerin is subjected to nitration reaction , under the nitrating mixture of conc sulfuric acid and nitric acid, in controlled condition of temperature. The process is very critical , Nitroglycerin is also has a explosive property hence is handled very carefully during manufacturing.

There other molecules like isosorbide dinitrate , and isosorbide mononitrate which are used as vasodilator in treatment of  congestive heart disease and angina .

Mode of action of nitroglycerin:
It is believed that nitroglycerin molecule releases NO through nitrite (NO2 −) which are responsible for vasodilation .

Following are some of articles which; will be useful for you in further understanding of aspects of sterile dosage form manufacturing and regulatory affairs in pharmaceutical industry

Pharmaceutical Validation , types of validation in pharmaceutical manufacturing
http://whoguideline.blogspot.com/2010/03/validation-in-pharmaceutical.html

Requirements of documents for validation of sterilization process

http://whoguideline.blogspot.com/2009/11/us-fdas-requirements-of-documentation.html

How to investigate OOS out of specification results
http://whoguideline.blogspot.com/2009/09/how-to-investigate-out-of-specification.html

Determination of Phenol coefficient of a disinfectant
http://whoguideline.blogspot.com/2009/04/determination-of-phenol-coefficient.html

Sterility testing
http://whoguideline.blogspot.com/2009/04/sterility-testing-of-pharmaceuticals.html

Cleen Room Classification
http://whoguideline.blogspot.com/2010/02/clean-room-classification-aspects-of.html


Time limitations in sterile pharmaceuticals processing
http://whoguideline.blogspot.com/2010/02/time-limitations-in-aseptic-process.html

Aspects of validation of manufacturing process in sterile pharmaceuticals
http://whoguideline.blogspot.com/2010/02/aspects-of-validation-of-aseptic_26.html

Clinical Trials
http://whoguideline.blogspot.com/2010/03/clinical-trials-medical-research.html

Controlling Pyrogens in injectable dosage forms
http://whoguideline.blogspot.com/2010/03/pyrogens-and-depyrogenation-process-in.html


No comments:


What is 21 CFR Part 11, US FDA guidelines requirements of FDA compliance and CFR 21 Part 11.

What is a Site Master file of a pharmaceutical company

What is Generic Drug

What is Reference Listed Drug  ? ( RLD )

What is Pharmaceutical Equivalents

What is Pharmaceutical Alternatives

What is Therapeutic Equivalents

What are Post Market studies

Why a drug is bound to protein, What is protein binding?  What is drug absorption , distribution ?

Do Physical properties contribute to drug activity.

What is drug receptor , How a drug resistance occurs

Mechanism of drug resistance

What is drug interaction

Drug interaction, and its examples

What is first pass metabolism of a drug

What is What is 510(k) Clearances ?

What is 510(k) Clearances,

Premarket Notification for medical devices - PMN or 510(k)

What is a drug interaction

Examples of drug interactions


Antibiotic Definition and classification


Antibiotic Resistance and Antibiotic resistance mechanism

Antioxidants food supplements

Vitamin D Details on FDA cautions on accurate dosage of Vitamin D


What is an antibody? what is monoclonal and polyclonal antibodies?

Terminologies In vaccine Production

Multi stage testing of Virus vaccine production

Testing of vaccines at different stages of production

TESTING FOR ADVENTITIOUS AGENTS CELL PROPERTIES IN VIRAL VACCINE PRODUCTION

Enzyme linked immunosorbent assay ELISA

Raido Immuno assay

http://whoguideline.blogspot.com/2010/04/terminalogy-and-their-explanations.html

Pharmaceutical Aseptic Manufacturing Process Terms , Terminology and Definitions.

http://whoguideline.blogspot.com/2010/02/pharmaceutical-aseptic-manufacturing.html

Here are some articles which will be useful for you in further understanding of aspects of sterile dosage form manufacturing and regulatory affairs and good manufacturing practice in

pharmaceutical industry

Pharmaceutical Validation

Types of validations in pharmaceutical manufacturing


Requirements of documents for validation of sterilisation process

How to investigate OOS out of specification results

Determination of Phenol coefficient of a disinfectant

Sterility testing

Clean Room Classification

Time limitations in sterile pharmaceuticals processing

Aspects of validation of manufacturing process in sterile pharmaceuticals

Clinical Trials

Requirements of US FDA Inspections of Clinical Investigators of Clinical Trials

PROCEDURE OF AN INSPECTIONS OF CLINICAL TRIAL INVESTIGATOR BY US FDA HOW ARE CLINICAL INVESTIGATOR INSPECTIONS CONDUCTED?

US FDA INSPECTION OF CLINICAL INVESTIGATORS OUT OF UNITED STATES OF AMERICA

REPORTS AFTER AN INSPECTION OF A INVESTIGAOTR OF CLINICAL TRIALS

Controlling Pyrogens in injectable dosage forms

Media fill run process simulation aspects Validation of Aseptic Process and Sterilisation

New Drug Application (NDA) how to make a New Drug Application (NDA) to US FDA

Abbreviated New Drug Application (ANDA) What is ANDA , detailed information about ANDA preparation and submission to US FDA

How to make Investigational New Drug (IND) Application to US FDA

Drug applications submission to us fda Over the counter Drugs OTC drugs

BIOAVAILABILITY AND BIOEQUIVALENCE REQUIREMENTS

Electronic record in pharmaceutical manufacturing industry

Good manufacturing practice in pharmaceutical industry

Pharmaceutical industry pharmaceutical companies and FDA latest updates